Publication | Closed Access
Fatal metabolic acidosis in a pediatric patient receiving an infusion of propofol in the intensive care unit
120
Citations
18
References
1995
Year
Acute Lung InjuryCritical Care ManagementCritical Care MedicineFatal Metabolic AcidosisIntensive Care UnitAcute CarePatient SafetyZeneca PharmaceuticalsPediatric GastroenterologySepsisPulmonary MedicinePediatric PatientDiprivan Registered TrademarkMetabolismMedicineAcute MedicinePediatric Intensive CareAnesthesiology
From the Critical Care Service, Department of Anesthesiology, Mayo Clinic and Mayo Foundation, Rochester, MN. No funding support was provided for this study, although the authors have received funding from Zeneca Pharmaceuticals to study Diprivan Registered Trademark in a septic porcine model of acute lung injury. Address requests for reprints to: Robert A. Strickland, MD, Mayo Clinic, 200 First Street, SW, Rochester, MN 55905.
| Year | Citations | |
|---|---|---|
Page 1
Page 1